COPS5 and breast cancer: It was also demonstrated that recurrent breast cancer patients had significant higher COPS5 expression than those primary tumors (Figure 3B, middle), which was in agreement with analysis from online database that COPS5 mRNA expression levels in recurrent breast cancer patients are significant higher than non-recurrent tumors (Figrue 3B, right).